Testing effectiveness (Phase 2)Active Not RecruitingNCT03012321
What this trial is testing
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Who this might be right for
Prostate Cancer Metastatic Castration-ResistantAbnormal DNA RepairMetastatic Prostate Carcinoma+1 more
Northwestern University 70